| Pharmaceutical active ingredients: |
| Nadroparin Calcium |
| Available forms, composition and doses of Fraxiforte: |
| Injectable; Injection; Nadroparin Calcium 11,400 IU / 0.6 mlInjectable; Injection; Nadroparin Calcium 15,200 IU / 0.8 mlInjectable; Injection; Nadroparin Calcium 19,000 IU / ml |
| Fraxiforte medical category: |
| Human:Anticoagulants, antiplatelets and fibrinolytics (thrombolytics)Heparins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B01AB06 - Nadroparin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineSanofi-Aventis |